Visterra, Inc.
Records under this name other than the patents Visterra, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 38 patents it holds.
Showing 1 to 2 of 2 · Back to Visterra, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,716,469 | Synthetic oligosaccharides for Moraxella vaccine Formerly held Lapsed on the fee record Ended May 6, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2022 | From the USPTO record |
| US 9,447,133 | Synthetic oligosaccharides for moraxella vaccine Lapsed on the fee record Ended Sep 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2020 | From the USPTO record |